AN HPV16 E6/E7 synthetic overlapping long-peptide vaccine in women with high-grade cervical squamous intraepithelial lesions

Trial Profile

AN HPV16 E6/E7 synthetic overlapping long-peptide vaccine in women with high-grade cervical squamous intraepithelial lesions

Discontinued
Phase of Trial: Phase II

Latest Information Update: 01 Sep 2012

At a glance

  • Drugs ISA 101 (Primary)
  • Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 01 Sep 2012
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top